Harding Loevner’s Celgene Corp CELG Stock Holding History

Harding Loevner’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-76	Closed	-$7K	–	158
2018 Q1	$7K	Buy	+76	New	+$7.3K	﹤0.01%	147

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harding Loevner's CELG Position: Q2 2018 in Review

Harding Loevner sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 76 shares — an estimated $7K sold.

Harding Loevner first reported a position in CELG in Q1 2018 and held it in 1 quarter. The position peaked at $7K in Q1 2018. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Harding Loevner reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Harding Loevner sold 76 Celgene Corp shares in Q2 2018, an estimated $7K.
Harding Loevner first reported a position in Celgene Corp in Q1 2018 and held it in 1 quarter.
Harding Loevner's Celgene Corp position peaked at $7K in Q1 2018.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Harding Loevner's 13F filing for Q2 2018, filed 14 Aug 2018.